Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against...

Area of Science:

• Microbiology
• Pharmacology
• Biochemistry

Background:

• Antibiotic-resistant Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA), poses a global health threat.
• Endocannabinoid/endocannabinoid-like (EC/EC-like) agents anandamide (AEA) and arachidonoyl serine (AraS) previously demonstrated antimicrobial effects against MRSA.

Purpose of the Study:

• To investigate the synergistic potential of combining AEA and AraS with various antibiotics against MRSA.
• To evaluate these combinations in both planktonic and biofilm growth conditions.

Main Methods:

• MRSA strains were cultured under planktonic and biofilm conditions.
• Combinations of AEA and AraS with antibiotics (ampicillin, gentamicin, methicillin) were tested for synergistic effects.
• Slime production and biofilm formation were assessed.

Main Results:

• Anandamide (AEA) and ampicillin (AMP), and arachidonoyl serine (AraS) and gentamicin (GEN) showed synergy in planktonic cultures.
• AEA and methicillin (MET) exhibited the highest synergy against MRSA biofilms.
• AraS and MET synergistically inhibited biofilm formation and impaired slime production.

Conclusions:

• Combinations of EC/EC-like agents and antibiotics demonstrate significant synergistic activity against MRSA.
• These combinations show promise in preventing MRSA biofilm formation, a critical factor in persistent infections.
• This research suggests a novel therapeutic strategy for combating MRSA infections.